|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Jan 31, 2025
|
FY2024
12 months to Jan 31, 2024
|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Non-cash operating lease cost | |||||
| Stock-based compensation | |||||
| Amortization of deferred contract acquisition costs | |||||
| Transaction costs expensed | |||||
| Change in fair value of common stock warrant liabilities | |||||
| Common stock warrant | |||||
| Redeemable convertible preferred stock warrant | |||||
| Total change in fair value of common stock warrant liabilities | |||||
| Change in fair value of contingent earnout liability | |||||
| ViriCiti | |||||
| Total change in fair value of contingent earnout liability | |||||
| Inventory impairment | |||||
| Gain on debt exchange | |||||
| Paid-in-kind non-cash interest expense | |||||
| Foreign currency transactions (gain) loss | |||||
| Reserves and other | |||||
| Changes in operating assets and liabilities, net of effect of acquisitions: | |||||
| Accounts receivable, net | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable, operating lease liabilities, and accrued and other liabilities | |||||
| Deferred revenue | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property and equipment | |||||
| Purchases of investments | |||||
| Maturities of investments | |||||
| Cash paid for acquisition, net of cash acquired | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from the exercise of public warrants | |||||
| Merger and PIPE financing | |||||
| Payment of tax withholding obligations on settlement of earnout shares | |||||
| Proceeds from issuance of debt, net of issuance costs | |||||
| Payments of transaction costs related to Merger | |||||
| Repayment of borrowings | |||||
| Change in driver funds and amounts due to customers | |||||
| Debt issuance costs | |||||
| Term Loan | |||||
| Revolving Credit Facility | |||||
| Total debt issuance costs | |||||
| Settlement of contingent earnout liability | |||||
| Proceeds from issuance of stock in connection with stock plans, net of withholding taxes | |||||
| Proceeds from issuance of common stock in connection with ATM offerings, net of issuance costs | |||||
| Other financing activities | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Supplementary cash flow information | |||||
| Cash paid for interest | |||||
| Cash paid for taxes | |||||
| Supplementary cash flow information on non-cash investing and financing activities | |||||
| Impact of convertible note modification | |||||
| Right-of-use assets obtained in exchange for lease liabilities | |||||
| Impairment charges and accelerated depreciation of right-of-use assets due to reorganization | |||||
| Acquisitions of property and equipment included in accounts payable and accrued and other current liabilities | |||||
| Vesting of early exercised stock options | |||||
| Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization | |||||
| Reclassification of Legacy ChargePoint redeemable convertible preferred stock warrant liability upon the reverse capitalization | |||||
| Contingent earnout liability recognized upon the closing of the reverse recapitalization | |||||
| Reclassification of remaining contingent earnout liability upon triggering event | |||||
| Issuance of Common Stock for contractual Interest Shares* | |||||
Loading...